|
|
Article: Wallace Laboratories Seasonal Allergic Rhinitis drug Astelin (Azelastine HCL) nasal spray approved for marketing by FDA.
- Article from:
- Business Wire
- Article date:
- November 4, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CRANBURY, N.J.--(BUSINESS WIRE)--Nov. 4, 1996--The Food and Drug Administration today announced approval of Astelin(R) (azelastine HCL) nasal spray, from Wallace Laboratories, for a complex of systems associated with seasonal allergic rhinitis.
ASTELIN(R) enters the $1.5 billion prescription seasonal allergic rhinitis market and is the first prescription antihistamine spray for seasonal allergic rhinitis in the United ...